PICC | Jotup

New Access Vascular Clinical Studies Find Catheters Composed of Advanced Biomaterials Significantly Reduce Complication Rates

Retrieved on:

Monday, September 20, 2021

Patent, Water, Patient, FDA, Deep vein thrombosis, Catheter, Association, AVA, CEO, Access, Family, PICC, Technology, DVT, Thrombosis, Phlebitis, Infection, AVI, Data analysis, GLOBE, RN, Medical imaging

Presented at the Association for Vascular Access (AVA) Annual Scientific Meeting 2021, these early findings highlight the potential for catheters made from advanced biomaterials to reduce patient risks, clinician frustration, and medical expense in vascular access and other applications.

Key Points:

Presented at the Association for Vascular Access (AVA) Annual Scientific Meeting 2021, these early findings highlight the potential for catheters made from advanced biomaterials to reduce patient risks, clinician frustration, and medical expense in vascular access and other applications.
The first retrospective clinical study compared complication rates such as occlusions and replacements in 61 standard PICCs and 60 HydroPICCs, respectively.
The second retrospective study compared complication rates of occlusions, replacements, deep vein thrombosis (DVT), and phlebitis in 100 standard midline catheters and 100 HydroMID catheters.
This clinical data proves its possible to transform patient outcomes and significantly reduce total medical expenses, said James Biggins, CEO of Access Vascular.

UltraDrape Reduces Cost of Ultrasound-Guided PIV Insertions, Increases Safety & Efficiency

Retrieved on:

Thursday, September 9, 2021

Dr. Moureau is an internationally recognized expert in vascular access and CEO of PICC Excellence. She conducted a cost analysis to examine the economic advantages of using UltraDrape in conjunction with Aseptic Non Touch Technique (ANTT®) -- a unique, standardized approach to aseptic technique -- during UGPIV procedures. Dr. Moureau will present her research as a poster at the upcoming Association of Vascular Access (AVA) Annual Scientific Meeting and will be available for discussion.

Key Points:

She conducted a cost analysis to examine the economic advantages of using UltraDrape in conjunction with Aseptic Non Touch Technique (ANTT) -- a unique, standardized approach to aseptic technique -- during UGPIV procedures.
Dr. Moureau compared the cost of supplies for three PIVC insertion techniques: UltraDrape/ANTT, current practice and full sterile insertion.
The use of UltraDrape resulted in significant cost savings, especially compared to the supplies required for a full sterile technique.
"UltraDrape is the direct result of our commitment to developing technologies that improve patient safety by enabling a safer, more efficient aseptic technique."

Access Vascular Inc. and Association for Vascular Access partner to champion clinicians leading care transformation at their institutions

Retrieved on:

Thursday, September 9, 2021

BEDFORD, Mass., Sept. 9, 2021 /PRNewswire/ -- Access Vascular, Inc. (AVI), a company addressing the most common and costly vascular access complications, today announced it has formed a strategic partnership with Association for Vascular Access (AVA). The goal of the partnership is to join forces in improving patient outcomes through evidence-based practices and clinical education around advanced technology applications.

Key Points:

BEDFORD, Mass., Sept. 9, 2021 /PRNewswire/ -- Access Vascular, Inc. (AVI) , a company addressing the most common and costly vascular access complications, today announced it has formed a strategic partnership with Association for Vascular Access (AVA).
AVI portfolio was developed and launched in response to these unmet needs expressed by vascular access teams and hospitals across the globe.
"AVI exists to transform the field of vascular access and champion clinicians in this space.
It is our sole mission, and it aligns well with AVA's vision for a world with safe and reliable vascular access," said James Biggins, CEO of Access Vascular.

PICC DESIGN® PICC Line Arm Sleeves Receive Patent Approval

Retrieved on:

Thursday, September 2, 2021

Patient, Patent, United States patent law, Caregiver, USPTO, Quality of life, PICC, Survivor, Organization, Cancer, Infection, Research, Pharmaceutical industry

HOUSTON, Texas, Sept. 2, 2021 /PRNewswire-PRWeb/ -- PICC DESIGN PICC line arm sleeves are for use by patients undergoing treatment for cancer, infectious disease, and other diagnoses that use a PICC line.

Key Points:

HOUSTON, Texas, Sept. 2, 2021 /PRNewswire-PRWeb/ -- PICC DESIGN PICC line arm sleeves are for use by patients undergoing treatment for cancer, infectious disease, and other diagnoses that use a PICC line.
PICC DESIGN sleeve designs are protective garments made with high-quality technical fabrics and come in two easy-to-wear designs and are officially patent designs with the US Patent & Trademark office (USPTO).
Every PICC DESIGN sleeve provides attractive, comfortable coverage with unique features for convenient use every day.
To learn more and to order PICC DESIGN sleeves, please visit: http://www.piccdesign.com
PICC DESIGN creates attractive & functional specialty products for survivors undergoing treatments that require a PICC line.

Enterprise-Grade Blockchain Solution Provider VeChain Creates New SaaS Products For China's Digital Carbon Emissions Market

Retrieved on:

Wednesday, August 25, 2021

China is arguably facing the greatest challenge of all, having vowed to reach net-zero emissions by 2060, with carbon emissions peaking no later than 2030.

Key Points:

China is arguably facing the greatest challenge of all, having vowed to reach net-zero emissions by 2060, with carbon emissions peaking no later than 2030.
VeChain, with its enterprise-grade public blockchain technology, is seizing the opportunity to play a crucial role in China's carbon reduction ambitions.
VeChain's brand new Digital Carbon Footprint SaaS Service is a powerful, rapidly deployable tool, enabling enterprises of all sizes to re-engineer their carbon footprint data management practices.
VeChain's Digital Carbon Footprint SaaS Service allows enterprise users to log key data and integrate it with world-leading third-party assurance providers within VeChain's partnership network.

Enterprise Public Blockchain VeChain Helps Growing Brand Deliver Highest-Quality Extra-Virgin Premium Olive Oils To Health Conscious Chinese Consumers

Retrieved on:

Thursday, August 19, 2021

Olive oil is one such commodity that has seen an explosion in demand thanks to its many well-established health benefits in the Chinese market.

Key Points:

Olive oil is one such commodity that has seen an explosion in demand thanks to its many well-established health benefits in the Chinese market.
Between 2020/21, The International Olive Council estimated that olive oil consumption in China will reach 66,000 tons per annum.
A rising brand, 'Olive Times', is taking advantage of this rapidly growing market.
Based in the Gansu Province, the most prestigious olive production region in China, the company has launched an ultra-premium extra virgin olive oil; Special-Olive.

VeChain Further Enables Producers Market To Bring the Competitive Benefits of Public Blockchain Technology To America's Family Farms

Retrieved on:

Wednesday, August 18, 2021

Enter Producers Market & VeChain - long-standing partners who continue to collaborate and unlock the competitive benefits of blockchain technology for producers and farmers worldwide.

Key Points:

Enter Producers Market & VeChain - long-standing partners who continue to collaborate and unlock the competitive benefits of blockchain technology for producers and farmers worldwide.
Producers Market and Storybird chose VeChain to support blockchain integration due to its easy-to-deploy, cost-effective and scalable design.
With Producers Market and VeChain working behind-the-scenes, Oatman Farms can focus on what it does best: produce delicious wholegrain, nutrient-dense baking mixes.
VeChain is the pioneer of real-world applications using public blockchain technology, with international operations in Singapore, Luxembourg, Tokyo, Shanghai, Paris, Hong Kong, and San Francisco.

Enterprise Public Blockchain VeChain Pushes One Million USD Grant Program

Retrieved on:

Friday, August 13, 2021

SINGAPORE, Aug. 13, 2021 /PRNewswire/ --As the world's preeminent enterprise public blockchain, VeChain's mission has always been to drive innovation, disruption and digitization through the application of blockchain technology at mass scale.

Key Points:

SINGAPORE, Aug. 13, 2021 /PRNewswire/ --As the world's preeminent enterprise public blockchain, VeChain's mission has always been to drive innovation, disruption and digitization through the application of blockchain technology at mass scale.
Standing at the forefront of blockchain mass adoption, the VeChain research team raised the idea of the next game-changer for the industry: the Enterprise NFT (eNFT - enterprise nonfungible token) ecosystem.
To achieve this goal, VeChain has committed $1 Million USD to fund a brand-new VeChain Grant Program.
Launched in 2015, the VeChain Foundation has worked tirelessly to build the bridges between blockchain technology and the real world.

VeChain Is Targeting The Multi-billion Dollar Chinese Pet Food Traceability Market Using Industry Leading Blockchain Technology

Retrieved on:

Friday, August 13, 2021

Without unified industry standards, in particular food quality standards, low-quality and counterfeiting pet foods are still prevalent in the market.

Key Points:

Without unified industry standards, in particular food quality standards, low-quality and counterfeiting pet foods are still prevalent in the market.
The choices of pet foods in the Chinese market have become a tug-of-war between pet owners, brands, press news and social media.
Blockchain technology enables accurate traceability of ingredients, allowing pet food manufacturers to solve biosecurity problems and quickly bring health concerns about pet food safety under control.
With blockchain technology, pet owners can trust ingredient listings are accurate because pet food recipes and the ingredients used have been stored on the blockchain.

Enterprise Public Blockchain VeChain Pushes One Million USD Grant Program

Retrieved on:

Friday, August 13, 2021

SINGAPORE, Aug. 13, 2021 /PRNewswire/ --As the world's preeminent enterprise public blockchain, VeChain's mission has always been to drive innovation, disruption and digitization through the application of blockchain technology at mass scale.

Key Points:

SINGAPORE, Aug. 13, 2021 /PRNewswire/ --As the world's preeminent enterprise public blockchain, VeChain's mission has always been to drive innovation, disruption and digitization through the application of blockchain technology at mass scale.
Standing at the forefront of blockchain mass adoption, the VeChain research team raised the idea of the next game-changer for the industry: the Enterprise NFT (eNFT - enterprise nonfungible token) ecosystem.
To achieve this goal, VeChain has committed $1 Million USD to fund a brand-new VeChain Grant Program.
Launched in 2015, the VeChain Foundation has worked tirelessly to build the bridges between blockchain technology and the real world.